Overview
Qualifyze provides audit solutions for the pharmaceutical and supply chain sectors by offering a large database of GxP audit reports and tools to plan, organize, and conduct audits. Users can search or download existing audits or join scheduled audits, with revenue coming from subscriptions and direct report purchases. It differentiates itself as a one-stop audit platform that centralizes reports and streamlines audit workflows, reducing procurement and coordination compared with traditional methods. Its goal is to improve the efficiency and reliability of global pharmaceutical supply chains by making audits easier to find, join, and manage while ensuring regulatory compliance.
Work here?Claim your company
Simplify's take
What believers are saying
- The April 2026 Quality Insights launch deepens wallet share beyond basic audit reports.
- September 2024’s $54 million round supports U.S. expansion and product investment.
- October 2026 updates show 150-plus monthly audits, reinforcing network effects and recurring demand.
What critics are saying
- Big pharma can replicate shared audits in-house, shrinking Qualifyze’s database advantage by 2027.
- Qualifyze’s AI claims face liability if audit data or CAPA tracking misses supplier failures.
- If FDA or EMA reject third-party report reuse, the audit-library model collapses quickly.
What makes Qualifyze unique
- Qualifyze’s 6,000-plus GxP audit library is unmatched as of October 2026.
- Its 250-plus local auditors cover 85-plus countries, compressing qualification timelines.
- Quality Insights, launched April 2026, turns audit data into supplier-risk intelligence.
Help us improve and share your feedback! Did you find this helpful?
Funding
Industry standards